Clinical Response to a Lapatinib-Based Therapy for a Li-Fraumeni Syndrome Patient with a Novel HER2(V659E) Mutation
Author:
Serra, Violeta; Vivancos, Ana; Suárez Puente, Xosé Antón
; Felip, Enriqueta; Silberschmidt, Daniel; Caratù, Ginevra; Parra, Josep-Lluís; Mattos Arruda, Leticia de; Grueso, Judit; Hernández-Losa, Javier; Arribas, Joaquín; Prudkin, Ludmila; Nuciforo, Paolo; Scaltriti, Maurizio; Seoane Leston, Juan; Baselga, José

Publication date:
2013
Publisher version:
Citación:
Cancer Discovery, 3(11), p. 1238-1244 (2013); doi:10.1158/2159-8290.CD-13-0132
Descripción física:
p. 1238-1244
Identificador local:
20141081
Patrocinado por:
This work has been supported by the European Research Council grants (ERC AdG09 250244 to J. Baselga and ERC 205819 to J. Seoane), Instituto de Salud Carlos III (ISCIII) grants (PSO9/00623 to J. Baselga, PI070648 to J. Seoane, and PI1202536 to J. Arribas), and Redes Temáticas de Investigación Cooperativa en Salud (RETIC)-ISCIII (RD06/06/0020/0075 to J. Baselga, RD12/0036/0043 to J. Seoane, and RD12/0036/0042 to J. Arribas), Asociación Española contra el Cáncer AECC grants (to J. Seoane and J. Arribas), a Rafael del Pino Foundation grant (to J. Baselga), a private donation from the Orozco family through the Oncology Research Foundation, FERO (to J.Baselga), and the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (to J. Baselga).
Collections
- Artículos [36888]